Principal Financial Group Inc. Buys 10,670 Shares of CVS Health Corporation $CVS

Principal Financial Group Inc. increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 0.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,378,796 shares of the pharmacy operator’s stock after acquiring an additional 10,670 shares during the quarter. Principal Financial Group Inc. owned approximately 0.11% of CVS Health worth $103,947,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. SOA Wealth Advisors LLC. raised its position in shares of CVS Health by 36.9% during the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 131 shares during the period. Symmetry Partners LLC increased its stake in CVS Health by 2.5% during the 3rd quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock valued at $439,000 after purchasing an additional 141 shares in the last quarter. Harbor Capital Advisors Inc. raised its holdings in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 142 shares during the last quarter. HF Advisory Group LLC lifted its stake in shares of CVS Health by 2.9% in the third quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock valued at $393,000 after buying an additional 145 shares in the last quarter. Finally, United Asset Strategies Inc. grew its holdings in shares of CVS Health by 1.8% during the third quarter. United Asset Strategies Inc. now owns 8,852 shares of the pharmacy operator’s stock valued at $667,000 after buying an additional 154 shares during the last quarter. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Up 1.2%

Shares of NYSE:CVS opened at $75.43 on Tuesday. CVS Health Corporation has a 1 year low of $53.36 and a 1 year high of $85.15. The company has a market capitalization of $95.76 billion, a PE ratio of 198.51, a price-to-earnings-growth ratio of 0.69 and a beta of 0.50. The business has a fifty day moving average price of $78.85 and a two-hundred day moving average price of $75.33. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health’s payout ratio is currently 700.00%.

Analysts Set New Price Targets

CVS has been the topic of a number of analyst reports. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Wells Fargo & Company lowered their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research note on Thursday, November 13th. Raymond James Financial lifted their target price on CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st. Mizuho increased their price target on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, December 10th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Nineteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $94.82.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.